Related references
Note: Only part of the references are listed.Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
Edith Christiane Bougouma et al.
FRONTIERS IN IMMUNOLOGY (2022)
Scientists hail historic malaria vaccine approval — but point to challenges ahead
Amy Maxmen
NATURE (2021)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Characteristic features of the SERA multigene family in the malaria parasite
Nobuko Arisue et al.
PARASITES & VECTORS (2020)
First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3)
Sachiko Ezoe et al.
VACCINE (2020)
Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study
Daniel J. Weiss et al.
LANCET (2019)
MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms
Sudhir Kumar et al.
MOLECULAR BIOLOGY AND EVOLUTION (2018)
Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5
Takahiro Tougan et al.
SCIENTIFIC REPORTS (2018)
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
Masanori Yagi et al.
SCIENTIFIC REPORTS (2016)
Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle
Robert Stallmach et al.
MOLECULAR MICROBIOLOGY (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods
Alfred B. Tiono et al.
PLOS ONE (2014)
Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences
Masanori Yagi et al.
PLOS ONE (2014)
Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications
Amed Ouattara et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: A pilot study
Tonny J. Owalla et al.
PARASITOLOGY INTERNATIONAL (2013)
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
Nirianne Marie Q. Palacpac et al.
PLOS ONE (2013)
Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5
Kazuyuki Tanabe et al.
VACCINE (2012)
Continuing Intense Malaria Transmission in Northern Uganda
Carla Proietti et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Mahamadou A. Thera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate
Nirianne Marie Q. Palacpac et al.
VACCINE (2011)
Plasmodium falciparum Accompanied the Human Expansion out of Africa
Kazuyuki Tanabe et al.
CURRENT BIOLOGY (2010)
Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows
Laurent Excoffier et al.
MOLECULAR ECOLOGY RESOURCES (2010)
Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36
Toshihiro Horii et al.
PARASITOLOGY INTERNATIONAL (2010)
DnaSP v5: a software for comprehensive analysis of DNA polymorphism data
P. Librado et al.
BIOINFORMATICS (2009)
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
Bernhards R. Ogutu et al.
PLOS ONE (2009)
Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
Shannon L. Takala et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes
Sharon Yeoh et al.
CELL (2007)
High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children
RN Okech et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth
S Aoki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of proteases involved in the processing of Plasmodium falciparum serine repeat antigen (SERA)
J Li et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda
BA Okech et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
